Breaking: Supreme Court overturns Roe v. Wade

The U.S. Supreme Court has decided to overturn Roe v. Wade, which guaranteed the Constitutional right to abortion access for nearly 50 years. 

The move was not surprising after a leaked draft opinion was published in early May. The highest court ruled 6-3 to overturn the law. The court’s majority opinion was written by Justice Samuel Alito, who penned the leaked draft opinion, as well.

“The Constitution makes no reference to abortion, and no such right is implicitly protected by any constitutional provision, including the one on which the defenders of Roe and Casey now chiefly rely — the Due Process Clause of the Fourteenth Amendment,” Alito wrote. “That provision has been held to guarantee some rights that are not mentioned in the Constitution, but any such right must be ‘deeply rooted in this Nation’s history and tradition’ and ’implicit in the concept of ordered liberty.”

 The lynchpin case stemmed from Dobbs v. Jackson Women’s Health Organization, a case about Mississippi’s law that banned nearly all abortion afters 15 weeks of pregnancy. Many states are expected to implement abortion bans and restrictions as a result of the court’s decision.

Health Exec will continue to update this is a breaking news story.

Related Content:

Biden responds to leaked Supreme Court draft opinion overturning Roe v. Wade

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.